Nomura Holdings Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

A detailed history of Nomura Holdings Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 10,685 shares of ARWR stock, worth $208,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,685
Holding current value
$208,678
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.36 - $29.54 $206,861 - $315,634
10,685 New
10,685 $206,000
Q2 2023

Aug 14, 2023
SELL
$25.16 - $41.38 $6.49 Million - $10.7 Million
-257,817 Reduced 33.87%
503,330 $17.9 Million
Q1 2023

May 15, 2023
BUY
$23.68 - $38.51 $2.64 Million - $4.3 Million
111,599 Added 17.18%
761,147 $19.3 Million
Q4 2022

Feb 14, 2023
BUY
$28.0 - $40.56 $17.7 Million - $25.7 Million
633,827 Added 4031.72%
649,548 $26.3 Million
Q3 2022

Nov 15, 2022
SELL
$29.63 - $48.31 $5.84 Million - $9.53 Million
-197,200 Reduced 92.62%
15,721 $520,000
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $5.52 Million - $10.1 Million
198,799 Added 1407.73%
212,921 $7.66 Million
Q1 2022

May 18, 2022
SELL
$39.62 - $69.97 $5.55 Million - $9.81 Million
-140,176 Reduced 90.85%
14,122 $695,000
Q4 2021

Feb 14, 2022
BUY
$58.09 - $82.51 $852,180 - $1.21 Million
14,670 Added 10.51%
154,298 $10.2 Million
Q3 2021

Nov 15, 2021
SELL
$58.38 - $84.96 $2.13 Million - $3.09 Million
-36,422 Reduced 20.69%
139,628 $8.73 Million
Q2 2021

Aug 16, 2021
BUY
$62.15 - $90.32 $7.74 Million - $11.2 Million
124,462 Added 241.26%
176,050 $14.6 Million
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $12.1 Million - $17.8 Million
-197,069 Reduced 79.25%
51,588 $3.43 Million
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $10.5 Million - $20.5 Million
239,707 Added 2678.29%
248,657 $19.1 Million
Q3 2020

Nov 12, 2020
SELL
$33.21 - $51.27 $141,142 - $217,897
-4,250 Reduced 32.2%
8,950 $385,000
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $1.14 Million - $1.9 Million
-43,800 Reduced 76.84%
13,200 $568,000
Q1 2020

May 14, 2020
BUY
$20.56 - $63.12 $1.17 Million - $3.6 Million
57,000 New
57,000 $1.64 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email